|drug1506||Hydroxychloroquin with Azithromycin Wiki||1.00|
|drug899||Convalescent plasma Wiki||0.21|
There is one clinical trial.
The COVID-19 pandemic is considered as the most crucial global health concern of the century. Given the complex interaction of physical and social factors on fast spreading infection, there have been increasing calls for comprehensive efforts using a community-based participatory research (CBPR) approach. CBPR partnership composed of representatives from community-based organisations, health and academia actively developed the present study. Specific aims were (1) to assess the efficacy and safety of Ayurvedic combination, Giloy (Tinospora Cordifolia) and Pippali (Piper longum) in the management of mild-to-moderate cases of COVID-19 and (2) to determine the effect in relieving COVID-19 symptoms and preventing the onset of severe infection.
Description: Clinical improvement was recorded by AiM COVID-19 App using numeric rating scaleMeasure: Time to COVID-19 symptoms relief Time: Up to 14-days
Description: Deterioration in clinical status from mild/moderate to severe/critical during the study period assessed by AiM COVID-19 AppMeasure: Prevention of severe stage of Covid19 Time: Up to 14-days
Description: Number of participants with intervention-related side effect/ adverse events as assessed by AiM COVID-19 AppMeasure: Side effect/ adverse events Time: Up to 14-days
Description: Number of participants requiring hospitalisationMeasure: COVID-19 severity worsening Time: Up to 14-days
Description: Time to positive-to-negative RT-PCR conversionMeasure: Time to negative saliva Time: Up to 14-days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports